CG Oncology, Inc. Common stock
NASDAQ:CGON · NASDAQ Global Select
+$1.35 today
Vol 1.80M · Avg 1.08M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+138.04%
Period High
$74.00
Period Low
$23.95
Latest
$61.08
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.16B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.54B
Legend Biotech Corporation
NASDAQ:LEGN
$5.43B
Travere Therapeutics, Inc.
NASDAQ:TVTX
$5.09B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.24B
Celcuity Inc.
NASDAQ:CELC
$4.20B
Disc Medicine, Inc.
NASDAQ:IRON
$2.72B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.72B
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$2.70B
Ascentage Pharma Group International
NASDAQ:AAPG
$398.35M
What is the latest CGON filing?
The latest filing shown is 4 dated Jun 16, 2026.
How many recent filings does CGON have?
Intrinsic Alpha currently shows 20 recent filings for CGON.
Explore More
Continue the stock analysis
Jump to another research area for this company.